{
    "nct_id": "NCT05423730",
    "official_title": "Effect of Light Alcohol Intake on Sex Hormone Levels Among Postmenopausal Women With ER+ Breast Cancer on Aromatase Inhibitor Therapy: The Alcohol and Breast Cancer (ABC) Trial",
    "inclusion_criteria": "* ER+ breast cancer\n* Female sex at birth\n* Postmenopausal, either natural or induced\n* Self-reported consumption of at least one alcoholic drink per week but not more than one serving per day\n* Currently prescribed aromatase inhibitors including anastrozole (Arimidex®), letrozole (Femara®), and exemestane (Aromasin®)\n* Documented liver function test results below 1.5X the upper limit of normal within 12 months of screening\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 21 Years\nMust have maximum age of 90 Years",
    "exclusion_criteria": "* Self-reported consumption of more than one drink per day, a previous or current history of alcohol abuse based on standard questionnaires (AUDIT≥8), or consumption of more than 4 or more drinks in one day within the last 6 months\n* Currently undergoing cytotoxic chemotherapy or radiation or planned in the next two months\n* Any surgery planned in the next two months\n* Alcohol flushing syndrome\n* Current use of any pharmaceutical agent contraindicated with alcohol, including warfarin, dual antiplatelet therapy, and metronidazole\n* Hemoglobin A1c>8% or a fasting glucose result above 180 mg/dL within 6 months of screening\n* Unable to speak or understand English\n* Unable to understand and provide informed consent, as judged by the study team",
    "miscellaneous_criteria": ""
}